Immutep Ltd. (IMMP)
3.86
-0.20
(-4.93%)
USD |
NASDAQ |
Oct 08, 15:57
Immutep Max Drawdown (5Y) : 95.17% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 95.17% |
| August 31, 2026 | 94.08% |
| July 31, 2026 | 94.08% |
| June 30, 2026 | 94.08% |
| May 31, 2026 | 94.08% |
| April 30, 2026 | 94.08% |
| March 31, 2026 | 93.28% |
| February 28, 2026 | 75.22% |
| January 31, 2026 | 75.22% |
| December 31, 2025 | 75.22% |
| November 30, 2025 | 75.22% |
| October 31, 2025 | 75.22% |
| September 30, 2025 | 75.22% |
| August 31, 2025 | 75.22% |
| July 31, 2025 | 75.22% |
| June 30, 2025 | 80.56% |
| May 31, 2025 | 85.21% |
| April 30, 2025 | 95.33% |
| March 31, 2025 | 96.60% |
| February 28, 2025 | 96.60% |
| January 31, 2025 | 96.60% |
| December 31, 2024 | 96.60% |
| November 30, 2024 | 96.60% |
| October 31, 2024 | 96.60% |
| September 30, 2024 | 96.60% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.60% |
| July 31, 2024 | 96.60% |
| June 30, 2024 | 96.60% |
| May 31, 2024 | 96.60% |
| April 30, 2024 | 96.60% |
| March 31, 2024 | 96.60% |
| February 29, 2024 | 96.60% |
| January 31, 2024 | 96.60% |
| December 31, 2023 | 96.60% |
| November 30, 2023 | 96.60% |
| October 31, 2023 | 96.60% |
| September 30, 2023 | 96.60% |
| August 31, 2023 | 96.60% |
| July 31, 2023 | 96.60% |
| June 30, 2023 | 96.60% |
| May 31, 2023 | 96.60% |
| April 30, 2023 | 96.60% |
| March 31, 2023 | 96.60% |
| February 28, 2023 | 96.60% |
| January 31, 2023 | 96.60% |
| December 31, 2022 | 96.60% |
| November 30, 2022 | 96.60% |
| October 31, 2022 | 96.60% |
| September 30, 2022 | 96.60% |
| August 31, 2022 | 96.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CSL Ltd. | 69.95% |
| Ceryvyn Therapeutics Ltd. | 99.95% |
| Propanc Biopharma, Inc. | 100.0% |
| Mesoblast Ltd. | 95.66% |
| Actinogen Medical Ltd. | 99.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -69.56 |
| Beta (5Y) | 2.274 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 70.71% |
| Historical Sharpe Ratio (5Y) | -0.6619 |
| Historical Sortino (5Y) | -0.9139 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.60% |